ADAPT Program for Post Intensive Care Syndrome
(ADAPT Trial)
Trial Summary
What is the purpose of this trial?
This pilot feasibility study will be a randomized control trial of usual care following Intensive Care Unit (ICU) discharge compared to the Anticipating Decline and Providing Therapy (ADAPT) screening and support intervention. The trial aims to enroll 120 older adults (age 60 or older).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the ADAPT treatment for Post Intensive Care Syndrome?
Is the ADAPT Program for Post Intensive Care Syndrome safe for humans?
How is the ADAPT treatment different from other treatments for post-intensive care syndrome?
The ADAPT treatment is unique because it focuses on anticipating decline and providing therapy early, which may include very early physical rehabilitation and case management interventions, unlike standard care that often involves later interventions. This proactive approach aims to improve long-term outcomes for ICU survivors by addressing physical, cognitive, and psychological health issues associated with post-intensive care syndrome.1231011
Research Team
Jessica Palakshappa, MD
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
This trial is for older adults aged 60 or above who have been discharged from the ICU and may be at risk of post-intensive care syndrome, dementia, or other cognitive impairments. Specific eligibility details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Cognitive Screening
Participants receive a routine validated cognitive screen at 6 weeks post-ICU discharge
Specialized Care Plan Development
Eligible participants complete a specialized care plan development visit
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Anticipating Decline and Providing Therapy (ADAPT)
- Usual Care post-Intensive Care Unit (ICU)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
National Institute on Aging (NIA)
Collaborator